Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,808,302
New position
Shares Held
11,160
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#1,695
of 4,153 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COMPASS FINANCIAL MANAGEMENT LLC holds $10,223,120 across 14 Drug Manufacturers - General names. ABBV ranks #1 (27.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
11,160 | $2,808,302 | |
| 2 | LLY |
ELI LILLY & Co
|
2,030 | $2,434,843 | |
| 3 | JNJ |
Johnson & Johnson
|
5,572 | $1,415,120 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
14,966 | $862,340 | |
| 5 | NVS |
Novartis AG
|
5,335 | $836,101 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,244 | $662,526 | |
| 7 | PFE |
Pfizer Inc
|
23,884 | $575,126 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,732 | $351,062 |
All Filings in ABBV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,808,302 | 11,160 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||